Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis

NCT01532336 is registered in ClinicalTrials.gov with NovaBay Pharmaceuticals, Inc. as lead sponsor.

NCT NCT01532336
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01532336 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
Lead sponsor
NovaBay Pharmaceuticals, Inc.
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2012
Completion date
August 31, 2014
Enrollment
500 (actual)
Sites
58

Conditions

As the registry lists them; a condition with its own page is linked.

adenoviral conjunctivitis